Article Source

• Evaluating AI models for structure-based drug design

Evaluating AI models for structure-based drug design

• Paper: https://arxiv.org/abs/2407.15595
• Speakers: Andrew Campbell

Abstract

Unlocking the Future of Drug Discovery with Generative AI!

In our second talk, Charlie Harris (Cambridge) and Martin Buttenschoen (Oxford) guide us through their recent papers, PoseCheck and PoseBusters. They highlight challenges and opportunities in evaluating AI models for structure-based drug design based on physical constraints. Subscribe and stay tuned for more enlightening discussions in this series!